March moves 2021
Investment firms
- Sofinnova Partners has closed €445M ($540M) oversubscribed late-stage healthcare crossover fund
- LSP has closed an upsized $120M Nasdaq IPO of European Biotech Acquisition Corporation (EBAC), the first healthcare SPAC to exclusively focus on European biotech
Analysts and banking
- Mick Ready has left Goldman Sachs to join the Investor Relations team at GSK
Media
- Sten Stovall has returned from sabbatical to his role as Editor and Writer at Scrip, In Vivo and The Pink Sheet
- Zachary Brennan is now a Senior Editor at Endpoints. He was previously a reporter at POLITICO
- Helen Thomas and Bryce Elder will be writing a column in Financial Times’ Lombard ‘slot’ focused on UK business
- Miles Costello has left The Times after 15 years on the business desk
- Josh Sullivan joins Endpoints News as an Associate Editor on the pharmaceutical manufacturing
- Megan Molteni will be joining STAT News on 5th April as a reporter. She is currently a staff writer at Wired
- Hannah Kulcher is currently the FT’s US Pharmaceuticals Reporter and will be moving back to London in April to start her new role as Global Pharmaceuticals Reporter
February moves 2021
Investment firms
- Pontifax raised $404M in a first and final close of Pontifax VI
- Abingworth raised $465M for new life sciences fund Abingworth Bioventures 8
- Adjuvant Capital announced $300M Venture Fund
- Advent Life Sciences closed two new funds at $215M
- Kate Bechtold has joined Vida Ventures as Senior Director, Investor Relations
Media
- Natasha Loder, Health Policy Editor and Alok Jha, Science Correspondent are hosts of The Economist’s new podcast, The Jab
- John Simons will start his new role as Executive Editor at TIME in March. He is currently Deputy Coverage Chief for Health & Science at The Wall Street Journal
- Rachel Addison has joined the Telegraph’s money desk. She was previously Senior Reporter at FTAdviser
- Imogen Tew is joining The Times’ Money Desk. She was previously Senior Reporter at FTAdviser
- Eleanor Malone is now Editor In Chief, Commercial Insights at
Informa Pharma Intelligence
January moves 2021
Investment firms
- Dr Allan Marchington joins Intermediate Capital Group plc (ICG), the global alternative asset manager as Managing Director and Head of ICG Life Sciences, joined by Dr Toby Sykes, Simon Tate, Dr Peter Kiener and Tracy Weightman. The team previously worked together at Bridge Valley Ventures
Analysts and banking
- James Orsborne has joined the healthcare research team at Stifel
- Cailin McGurk has joined Morgan Stanley as Managing Director, Investment
- Jonathan Beake joins Citi as specialist sales
Media
- Shivali Best has been appointed Deputy Science and Technology Editor at Mail Online. Previously she was the Deputy Science and Technology Editor at the Daily Mirror
- Matthew Sparkes has joined New Scientist as a Technology Reporter.
- Kate Galbraith has been appointed Health Editor at the San Francisco Chronicle.
- Conner Mitchell joined Endpoints as an Associate Editor
- Rebecca Szkutak joins Forbes as a reporter covering venture capital
- Katie Palmer and Mario Aguilar have joined STAT as Reporters
- Ben Spencer has been appointed Science Editor at The Sunday Times
- Patricia Kelly Yeo joined Business Insider (US) as Healthcare Fellow
- Ian Lopez will cover Pharmaceuticals at Bloomberg
- Julie Wernau has been appointed Reporter on the Health & Science team for the Wall Street Journal.
December moves 2020
Investment Firms
- Forbion closed its fifth Life Sciences fund at €460M
Analysts
- Kane Slutzkin has joined Numis as Healthcare Equity Research Director. He was previously at UBS
Media
- Kyle Blankenship has joined Endpoints as Senior Editor. He was previously at Fierce Pharma
- Kate Burgess FT Lombard Editor has left the publication
November moves 2020
Investment Firms
- Jon Edwards has joined Red Tree Venture Capital as managing director. He was previously at Medicxi
- Bruno Strigini joins PE firm Permira as a senior adviser focusing on healthcare
- Thuja Capital Management launches Thuja Capital Healthcare Fund III and expects to raise €75M to EUR €100M once fully completed
- SR One Completes Spin-out from GSK and Closes First Fund at $500 Million
Analysts
- Mark Hong has joined Bryan Garnier as Healthcare Investment banker, in London
Media
- Nicholas St. Fleur joined STAT as Science Reporter
- Kat Lay has been promoted to Health Editor of The Times
- Eliza Slawther has been appointed Pharma Reporter at APM Health Europe
- Catherine Schuster Bruce joined Business Insider UK as Healthcare Reporter
- Frank Vinluan has left Xconomy
- Adam Samson appointed Markets News Editor at the Financial Times
- Naomi Ackerman joined the Evening Standard as City Reporter
- Louise Moon joined The Daily Telegraph as Business Reporter
- Christian May, Editor of City AM, is leaving and will be temporarily replaced by Andy Silvester
October moves 2020
Investment firms
- Joe Anderson joined Sofinnova Partners as Partner in the Crossover Fund
- Jeroen Bakker Principal at Novo Seeds has joined Rappta Therapeutics’ Board
- Omega Funds’ Managing Director Claudio Nessi and Principal Francesco Draetta joined Chord Therapeutics’ Board
- Kate Rowley previously Investment Director for Bioscience Managers has been appointed Chief Business Officer at Abcodia Ltd
Media
- Olivia Goldhill has joined STAT News as Investigative Reporter, from Quartz
- Mark Latham appointed Editor of Private Equity News
- Stefan Wagstyl appointed Editor of both FT Money and FT Wealth
- Alex Lawson has started as Senior City Correspondent at the Mail on Sunday
- Emma Dunkley has been appointed as City Correspondent at The Mail on Sunday
September moves 2020
Investment firms
- Annalisa Jenkins appointed NED at Trustedoctor
- Edward Kliphuis joined Amadeus Capital while remaining an advisor at M ventures
- Jean Hynes to succeed Brendan Swords as CEO of Wellington Management in 2021
- Abhijeet Lele and Jon Levy appointed Senior Partners at Novo Holdings Principal Investments
- Bidhi Bhoma has been appointed Chief Executive Officer at Liberum Capital
Analysts
- Dr. Brian White and Andrew Keith found new firm Calvine Partners
Media
- Catherine Longworth joins pharmaphorum from Medtech Insight, Informa Pharma Intelligence
- Laurel Ives appointed Digital Health Editor at the Daily Telegraph
- Linda Geddes appointed Science Correspondent at the Guardian
August moves 2020
Investment firms
- Tony Scawthorn will be appointed as joint CEO of Zeus Capital Limited, alongside John Goold (STA)
- Muna Therapeutics Chief Scientific Officer Rita Balice-Gordon has joined Novo Seeds as Entrepreneur in Residence
Analysts
- Mick Cooper, previously an analyst at Trinity Delta has joined the BEIS, Office for Life Sciences.
Media
- Matt Atherton is now Health Reporter at the Daily Express
- John Simons has been appointed Deputy Health & Science Editor for the Wall Street Journal
- Karl Mathiesen has joined POLITICO Europe, based in Brussels
- Natalie Grover has left Endpoints News and is now Science Correspondent at The Guardian
- Peter Evans has left Sunday Times
- David Crow is no longer US Coronavirus Correspondent at Financial Times and is now covering US elections
- Ben Woods is re–joining The Daily Telegraph as Senior Business Reporter
- Drew Armstrong is now senior editor for Healthcare at Bloomberg Business
July moves 2020
Investment firms
- Claire Terlouw has joined LifeArc Ventures from Syncona
- Priya Mande has joined the UK Vaccine Taskforce on secondment from PsiOxus Therapeutics
- Regina Hodits, Managing Partner, Wellington Partners, is now a member of the board
Analysts and banking
- Richard Parkes has joined Exane as Equity Analyst from Deustche Bank
Media
- Joseph Walker, Healthcare Reporter, Wall Street Journal is now covering the European pharmaceutical industry.
- Harriet Clarfelt, Investment Writer, Investors Chronicle is now covering healthcare
- Lauren Wolf has joined Nature News as Bureau Chief for the Americas; she was previously Deputy Editorial Director at Chemical & Engineering News
- Kashmira Gander has been promoted to Deputy Science Editor at Newsweek (US) from Health Correspondent
June moves 2020
Investment firms
- Luc Debruyne and Gérard Lamarche appointed to the Board of Directors of Fund+
- Kemal Malik appointed as Non-Executive Director at Syncona
- Christian Schetter, PhD has been promoted to Managing Director at Arix Bioscience
- Graham Stafford has left Man GLG to join Endurant Capital as partner
Analyst and banking
- Dylan van Haaften has joined Bryan Garnier as Healthcare Equity Research Analyst
- James Mainwaring has joined Atlantic Equities from Stifel
Media
- Harriet Clarfelt is now covering the healthcare sector at Investors Chronicle
- Virginia Hughes has joined The New York Times as Editor for Health & Science
- Anna Gross is covering the ‘science of coronavirus’ for the Financial Times’ Science & Environment team
May moves 2020
Investment firms
- Tatiana Brask joined Novo Holdings A/S as Manager for Fund Investments in Novo Seeds
- Fiona MacLaughlin has joined J& J innovation – JJDC from INKEF
- Stephan Christgau has founded Eir Ventures
- Vinayak Nikam has left Vivo Capital
- Dr. Anja Harmeier left Roche and joined BB Pureos Bioventures
- Martijn Mulder left NIBC Bank and joined Ampersand Capital Partners
Analyst and banking
- Richard Parkes, Director, Pharmaceuticals Equity has left Deutsche Bank Securities
- Hugo Solvet left Bryan Garnier & Co. and joined Exane BNP Paribas
- Dorothea Hill left Hardman & Co and has joined GSK
Media
- Amber Tong has relocated to Hong Kong and has been promoted to Editor at Endpoints News
- Anna Smith has left PharmaTimes, where she was a Reporter
- David Brenchley has been appointed Acting Deputy News Editor at Investment Week
- Chloe Cheung has joined FT Adviser as a Reporter, covering investment platforms
- Adam Smith starts as Science and Technology Reporter at the Independent
- Lucy McNulty has been appointed City Editor at Financial News
April moves 2020
Investment firms
- Paul Sekhri and Sanford (Sandy) Zweifach joined Medicxi as Venture Partners
- Arix Bioscience appointed Dr. Naseem Amin as Executive Chairman, promoted Jonathan Tobin to Managing Director and John Cassidy to Principal
Analyst and specialist sales
- Kerry Holford and Luisa Hector have joined Berenberg from Exane to head up the Global Pharmaceutical Equity research
- Fowey Harvey joined Liberum from IQIVIA as Healthcare Analyst
- James Mainwaring has left Stifel
Media
- Mike Ward has joined Decision Resources Group, part of Clarivate as Global Head of Thought Leadership.
- Carlo Martuscelli left DJ/ WSJ to join POLITICO
- Helen Albert has left Labiotech and is now working as a freelance journalist
- Ben Fidler has joined Biopharma Dive from Xconomy
